Empirical view of opioid dependence

Journal of Managed Care Pharmacy

Volumn 16, Issue 1 SUPPL. B, 2010, Pages

  Ruetsch, Charles ^a  

^a Health Analytics LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; METHADONE; OPIATE; NARCOTIC ANALGESIC AGENT;

ABSENTEEISM; COST EFFECTIVENESS ANALYSIS; CRIMINAL BEHAVIOR; EMPIRICAL RESEARCH; EMPLOYER; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; MANAGED CARE; MANAGED CARE ORGANIZATION; OPIATE ADDICTION; PHYSICIAN; PRODUCTIVITY; REVIEW; SOCIAL ASPECT; UNITED STATES; CHRONIC DISEASE; COST OF ILLNESS; ECONOMICS; HEALTH INSURANCE; PAIN; PREDICTION AND FORECASTING; TREATMENT OUTCOME;

ABSENTEEISM; ANALGESICS, OPIOID; CHRONIC DISEASE; COST OF ILLNESS; EFFICIENCY; EMPLOYER HEALTH COSTS; HEALTH CARE COSTS; HUMANS; MANAGED CARE PROGRAMS; OPIOID-RELATED DISORDERS; PAIN; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 77950513055     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2010.16.s1-b.9     Document Type: Review

References (31)

1. Trescot AM, Boswell MV, Atluri SL, et al. Opioid guidelines in the management of chronic noncancer pain. Pain Physician. 2006;9(1):1-39. Available at: http://www.painphysicianjournal.com/2006/january/2006;9;1-40.pdf. Accessed January 24, 2010.
2. Bell K, Salmon A. Pain, physical dependence and pseudoaddiction: redefining addiction for "nice" people. Int J Drug Policy. 2009;20(2):170-178
3. National Institute on Drug Abuse. Pain, opioids, and addiction: physician concerns regarding prescribing opiates for chronic pain. Available at: http://www.nida.nih.gov/newsroom/07/NS-3.html. Accessed January 23, 2010.
4. Scott E, Borate U, Heitner S, et al. Pain management practices by internal medicine residents - a comparison before and after educational and institutional interventions. Am J Hosp Palliat Care. 2009;25(6):431-439
5. Sipkoff M. Opioid dependence affects society on many levels. Manag Care. 2009;1(1):4-10.
6. NIH. National Institute on Drug Abuse. Research report series: prescription drug abuse and addiction. Revised August 2005. Available at: http://wwwdrugabuse.gov/ResearchReports/Prescription/Prescription.html. Accessed January 24, 2010.
7. DHHS. Substance Abuse and Mental Health Services Administration. Center for Substance Abuse Treatment. Office of Applied Studies. Results from the 2007 national survey on drug use and health: national findings. NSDUH Series H-34, DHHS publication no. SMA 08-4343. September 2008. Available at: http://oas.samhsa.gov/nsduh/2k7nsduh/2k7Results.cfm#TOC. Accessed January 24, 2010.
8. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Arlington, VA: American Psychiatric Association; 2000.
9. Huang B, Dawson DA, Stinson FS, et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2006;67(7):1062-1073 (Pubitemid 44230877)
10. Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008;11(Suppl 2):S63-S88.
11. The Partnership for a Drug-Free America. Teens 2005 Report. Available at: http://www.drugfree.org/Portal/DrugIssue/Research/Teens-2005/Generation-Rx- Study-Confirms-Abuse-of-Prescription. Accessed January 19, 2010.
12. DHHS. Substance Abuse and Mental Health Services Administration. Center for Substance Abuse Treatment. Office of Applied Studies. Sources of payment for substance use treatment. NSDUH Report, Issue 10, 2006. Available at: http://www.oas.samhsa.gov/2k6/pay/pay.htm. Accessed January 24, 2010.
13. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. July 24, 2008. Non-pharmaceutical fentanyl-related deaths. Available at: http://www.cdc.gov/media/mmwrnews/2008/n080724.htm#1. Accessed January 24, 2010.
14. Fuhrman V. Illegal painkiller cited in overdose surge. Wall Street J. July 25, 2008. Available at: http://online.wsj.com/article/SB1216925022145839. html. Accessed January 24, 2010.
15. Birnbaum HG, White AG, Reynolds JL, et al. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a social perspective. Clin J Pain. 2006;22(8):667-676
16. U.S. Drug Enforcement Administration. Office of Diversion Control. Automation of Reports and Consolidated Orders System (ARCOS). Available at: http://www.deadiversion.usdoj.gov/arcos/retail-drug-summary/index.html. Accessed January 26, 2010.
17. Department of Justice, Drug Enforcement Administration. Office of Diversion Control. Retail drug summary. 1997-2006. Available at: http://www.deadiversion.usdoj.gov/arcos/retail-drug-summary/index.html. Accessed February 2, 2010.
18. Paulozzi LJ, Budnitz DS, Yongli X. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15(9):618-627
19. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. February 9, 2007. Unintentional poisoning deaths - United States, 1999-2004. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5605a1.htm. Accessed January 25, 2010.
20. Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA. 2007;297(3):249-251
21. Centers for Disease Control and Prevention. National Institute for Occupational Safety and Health. Musculoskeletal disorders and workplace factors: low-back musculoskeletal disorders: evidence for work-relatedness. 1997. Available at: http://www.cdc.gov/niosh/docs/97-141/pdfs/97-141f.pdf. Accessed January 24, 2010.
22. White AG, Birnbaum HG, Mareva MN, et al. Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005;11(6):469-479 Available at: http://www.amcp.org/data/jmcp/3.pdf.
23. Center for Substance Abuse Treatment. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2004. Available at: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.section.72303. Accessed January 24, 2010.
24. Ciccone DS, Just N, Bandilla EB, et al. Psychological correlates of opioid use in patients with chronic nonmalignant pain: a preliminary test of the downhill spiral hypothesis. J Pain Symptom Manage. 2000;20(3):180-192
25. Brooner RK, King VL, Kidorf M, Schmidt CW Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54:71-80. (Pubitemid 27044701)
26. National Institute of Mental Health. Depression. Available at: http://www.nimh.nih.gov/health/publications/depression/complete-index.shtml. Accessed January 24, 2010.
27. DHHS. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network, 2005: National Estimates of Drug-Related Emergency Department Visits. DAWN Series D-29; DHHS Publication no. (SMA) 07-4256, Available at: http://dawninfo.samhsa.gov/pubs/edpubs/default. asp. Accessed January 19, 2010.
28. American Pain Society. Advocacy & policy: definitions related to the use of opioids for the treatment of pain. American Pain Society website. Available at: http://www.ampainsoc.org/advocacy/opiods2.htm. Accessed January 24, 2010.
29. White AG, Birnbaum HG, Mareva MN, et al. Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005,11(6):469-479 Available at: http://www.amcp.org/data/jmcp/3.pdf.
30. Average price per prescription based on the prescription price estimator at Regence Blue Cross-Blue Shield on January 26, 2010. Available at: http://www.regencerx.com/learn/rxPriceGuide/index.html. Accessed January 26, 2010.
31. Rosenheck R, Kosten T. Buprenorphine for opiate addiction: potential economic impact. Drug Alcohol Depend. 2001;63(3):253-262